Cedars-Sinai Medical Center - Archive Alzheimers
Filter by year
2026
January
30,
2026
|
07:00 AM
America/Los_Angeles
Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai. Published in Nature Communications, the …
Read more
2025
August
28,
2025
|
06:00 AM
America/Los_Angeles
“Young” immune cells created by Cedars-Sinai investigators reversed signs of aging and Alzheimer’s disease in the brains of laboratory mice, according to a study published in the journal Advanced Science. The immune cells, which were produced from …
Read more
August
11,
2025
|
06:00 AM
America/Los_Angeles
Cedars-Sinai physician-scientists joined peers from around the world at the Alzheimer’s Association International Conference in July. The scientific presentations at the conference included data from clinical trials of potential therapies for the …
Read more
August
05,
2025
|
06:30 AM
America/Los_Angeles
In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin converting enzyme (ACE) in key immune cells called microglia in the brain helped protect the brains of specially bred laboratory mice against Alzheimer’s disease. …
Read more
April
25,
2025
|
09:00 AM
America/Los_Angeles
Prevention recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai, about the role of genetics in the development of Alzheimer’s disease—the most common form of …
Read more
2024
August
30,
2024
|
07:00 AM
America/Los_Angeles
Higher-than-average levels of two Alzheimer’s-associated proteins—amyloid beta and tau—in the brain are linked with poorer cognition in middle-aged adults, according to a study led by Cedars-Sinai investigators and published in Alzheimer’s & …
Read more
August
28,
2024
|
08:00 AM
America/Los_Angeles
Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain. The eye-brain connection could help physicians diagnose patients with …
Read more
June
24,
2024
|
06:00 AM
America/Los_Angeles
A machine learning tool developed by Cedars-Sinai investigators can answer questions about genes, drugs, and biochemical pathways associated with Alzheimer’s disease and other health conditions. Their findings were published today in the journal …
Read more
June
10,
2024
|
06:00 AM
America/Los_Angeles
Cedars-Sinai has launched a program to help people 40 and older who do not have Alzheimer’s disease but want to understand—and reduce—their risk for developing the illness.“After several decades of research, we understand that Alzheimer’s disease is …
Read more
February
28,
2024
|
06:30 AM
America/Los_Angeles
Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai. She will treat …
Read more
January
11,
2024
|
06:30 AM
America/Los_Angeles
Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is …
Read more
2023
August
22,
2023
|
06:00 AM
America/Los_Angeles
In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called …
Read more
July
06,
2023
|
07:01 AM
America/Los_Angeles
Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment that has received approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months. “This is the most promising …
Read more
